Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$498M |
| 2 |
Micron Technology
MU
|
+$374M |
| 3 |
Amazon
AMZN
|
+$356M |
| 4 |
Accenture
ACN
|
+$318M |
| 5 |
Advanced Micro Devices
AMD
|
+$301M |
Top Sells
| 1 |
Apple
AAPL
|
+$684M |
| 2 |
Meta Platforms (Facebook)
META
|
+$630M |
| 3 |
Tesla
TSLA
|
+$595M |
| 4 |
Chevron
CVX
|
+$497M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| 1 | Healthcare | 19.38% |
| 2 | Technology | 18.55% |
| 3 | Consumer Staples | 10.17% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3176
iShares US Financial Services ETF
IYG
$1.94B
| $325K | ﹤0.01% |
+6,900
| New | +$325K |
|
3177
MediciNova
MNOV
$62.3M
| $325K | ﹤0.01% |
149,800
-11,300
| -7% | -$24.5K |
|
3178
SPDR S&P Biotech ETF
XBI
$5.52B
| $325K | ﹤0.01% |
4,100
-7,100
| -63% | -$563K |
|
3179
Bogota Financial
BSBK
$117M
| $324K | ﹤0.01% |
29,414
-7,970
| -21% | -$87.8K |
|
3180
First Savings Financial Group
FSFG
$190M
| $324K | ﹤0.01% |
14,100
-2,600
| -16% | -$59.7K |
|
|
QIWI
3181
DELISTED
QIWI PLC
QIWI
| $324K | ﹤0.01% |
571,151
| – | – |
|
3182
AYTU BioPharma
AYTU
$20.5M
| $323K | ﹤0.01% |
87,376
+34,587
| +66% | +$128K |
|
3183
Invesco CurrencyShares Japanese Yen Trust
FXY
$563M
| $319K | ﹤0.01% |
+4,930
| New | +$319K |
|
3184
Sensei Biotherapeutics
SNSE
$10.7M
| $319K | ﹤0.01% |
10,290
-2,060
| -17% | -$63.9K |
|
3185
Stock Yards Bancorp
SYBT
$2.28B
| $319K | ﹤0.01% |
4,690
-4,700
| -50% | -$320K |
|
|
UPH
3186
DELISTED
UpHealth, Inc.
UPH
| $319K | ﹤0.01% |
59,905
-10,340
| -15% | -$55.1K |
|
3187
Dorchester Minerals
DMLP
$1.2B
| $317K | ﹤0.01% |
12,700
-136,400
| -91% | -$3.4M |
|
3188
Retractable Technologies
RVP
$24.5M
| $317K | ﹤0.01% |
160,211
+38,311
| +31% | +$75.8K |
|
3189
WisdomTree US LargeCap Dividend Fund
DLN
$5.33B
| $315K | ﹤0.01% |
+5,700
| New | +$315K |
|
|
SSBK
3190
DELISTED
Southern States Bancshares
SSBK
| $313K | ﹤0.01% |
11,493
-1,507
| -12% | -$41K |
|
3191
Varonis Systems
VRNS
$6.41B
| $313K | ﹤0.01% |
11,800
-241,694
| -95% | -$6.41M |
|
3192
Avantis US Equity ETF
AVUS
$9.64B
| $312K | ﹤0.01% |
5,000
-9,800
| -66% | -$612K |
|
3193
Applied Therapeutics
APLT
$64M
| $311K | ﹤0.01% |
334,289
+70,111
| +27% | +$65.2K |
|
3194
Eletrobras Preferred Shares
EBR.B
$20.1B
| $310K | ﹤0.01% |
36,600
+5,000
| +16% | +$42.4K |
|
|
ONC
3195
BeOne Medicines Ltd. American Depositary Shares
ONC
$34.5B
| $310K | ﹤0.01% |
+2,300
| New | +$310K |
|
3196
First Guaranty Bancshares
FGBI
$126M
| $309K | ﹤0.01% |
14,106
-1,900
| -12% | -$41.6K |
|
3197
MIND Technology
MIND
$65.1M
| $309K | ﹤0.01% |
48,250
-4,116
| -8% | -$26.4K |
|
3198
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $309K | ﹤0.01% |
+3,800
| New | +$309K |
|
3199
iShares MSCI Turkey ETF
TUR
$160M
| $309K | ﹤0.01% |
14,000
-100
| -0.7% | -$2.21K |
|
|
AGTC
3200
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $309K | ﹤0.01% |
1,137,508
+831,768
| +272% | +$226K |
|